Literature DB >> 28054013

The profile of Cyr61 expression data correlate to the skin inflammation in psoriasis.

Pinru Wu1, Gang Ma2, Ningli Li3.   

Abstract

The data presented in this article are related to the research article entitled "Cyr61/CCN1 is involved in the pathogenesis of psoriasis vulgaris via promoting IL-8 production by keratinocytes in a JNK/NF-κB pathway" (Pinru Wu, Gang Ma, Xianjin Zhu, Ting Gu, Jie Zhang, Yue Sun, Hui Xu, Rongfen Huo, Beiqing Wang, Baihua Shen, Xiangdong Chen, Ningli Li, 2016) [1]. Cysteine-rich 61 (Cyr61/CCN1), a secreted extracellular matrix protein, is a novel proinflammatory factor. In this dataset skin samples from normal donors and psoriasis vulgaris patients were examined the expression of Cyr61 and IL-8 using immunohistochemistry. IMQ-induced psoriasis-like mice were treated with anti-Cyr61monoclonal antibodies (mAb).

Entities:  

Keywords:  Cysteine-rich 61; Inflammation; Psoriasis

Year:  2016        PMID: 28054013      PMCID: PMC5196240          DOI: 10.1016/j.dib.2016.12.008

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


Specifications Table Value of the data This data characterizes the distribution of Cyr61 expression in skin lesion of patients with psoriasis vulgaris. These data could be used for developing improved strategy in the treatment of psoriasis.

Data

The dataset of this article provides information on the Cyr61 and IL-8 expression in skin lesion in psoriasis patients (Fig. 1, Fig. 2) and the change of the production of Cyr61 by specific siRNA in vitro and anti-Cyr61mAb in vivo (Fig. 3, Fig. 4).
Fig. 1

The occurrence and distribution of Cyr61 expression in skin lesion of patients with psoriasis vulgaris. The epidermal positive staining of Cyr61 varied from patient to patient: (a) darker staining in stratum basale, (b) darker staining in upper epidermal layers, (c) moderate staining in stratum spinosum, (d) isotype control. Bar 100 μm, Magnification ×100.

Fig. 2

Representative immunofluorescent staining of Cyr61 and IL-8 in the lesional skin of psoriasis patient. Bar 100 μm.

Fig. 3

The identification of specific siRNA of Cyr61. The siRNA of Cyr61 was identified in HaCaT cells, which could reduce Cyr61 expression by about 50% at mRNA levels. **P<0.01.

Fig. 4

Symptoms in psoriasis-like mice treated with 093G9 were significantly inhibited by blocking Cyr61. The multilayer silvery white scales in the back skin and the incrassation of the ears were decreased after blocking Cyr61 expression. **P<0.01.

Experimental design, materials and methods

Immunohistochemistry analysis of Cyr61 expression

Normal and lesional skin from human donors and mice were fixed in 4% paraformaldehyde, embedded in paraffin and sectioned. For immunohistochemistry, skin samples from patients were stained with anti-Cyr61 mAb at a concentration of 1:200 followed by HRP conjugated goat anti-mouse secondary antibody [1,2].

RNAi knockdown of gene expression

Cyr61, IL-1β and TNF-α small interfering RNA (siRNA, Table S2; see Supporting information) were designed and synthesized at Shanghai Genepharma (Shanghai, China) and gene knockdowns were performed as previously reported [3]. HaCaT cells were cultured in 24-well plates. A transfection mixture of siRNA oligonucleotides and Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA, USA) in serum-free medium was added to medium-aspirated cells for 4 h. Then, the medium was replaced with complete DMEM containing 10% fetal bovine serum for additional 24 h incubation.

Establishment and treatment of IMQ-induced psoriasis-like skin inflammation model in mice

For induction of the psoriasis-like skin inflammation model, mice received a daily topical dose of 62.5 mg of IMQ cream (5%) (Aldara, 3M Pharmaceutical, UK) on the shaved back and the right ear, representing a daily dose of 3.125 mg of the active compound. Control mice were treated similarly with vaseline (Vaseline Lanette cream, Fagron). Mice received intraperitoneal injections of 200 μg/day of either anti-Cyr61 mAb 093G9 or control IgG1 (Millipore, Billerica, MA, USA) 2 days after IMQ treatment. After16 days later mice were sacrificed and skin samples were collected and inspected [4].

Funding sources

This work was funded by National Natural Science Foundation of China (81473682, 81402618), Excellent Young Doctor Foundation of Shanghai Ninth People׳s Hospital (201608), Education Ministry Research Fund for the Doctoral Program (20130073110003), Science and Technology Commission of Shanghai Municipality (13JC1402300) and Shanghai Cultivate Outstanding Young Teachers in Colleges and Universities Scientific Research Fund (JDY09062).
Subject areaHealth sciences
More specific subject areaDermatology
Type of dataFigures, Text file
How data was acquiredNanoDrop ND-1000 Spectrophotometer, cDNA Synthesis Kit, Confocal laser scanning fluorescence microscopy
Data formatRaw and analyzed
Experimental factorsPsoriatic lesional skin of patients and IMQ-induced mice
Experimental featuresAnalyze the profile of Cyr61 expression in psoriatic lesion by Immunohistochemistry. qPCR was used for mRNA expression and protein expression by immunofluorescence studies.
Data source locationDepartment of Dermatology
Shanghai Ninth People׳s Hospital, Shanghai JiaoTong University School of Medicine 639, Zhizaoju Road, Huangpu District, Shanghai, P. R. China, 200011
Data accessibilityThe data are available with this article
  4 in total

1.  Cyr61/CCN1 is involved in the pathogenesis of psoriasis vulgaris via promoting IL-8 production by keratinocytes in a JNK/NF-κB pathway.

Authors:  Pinru Wu; Gang Ma; Xianjin Zhu; Ting Gu; Jie Zhang; Yue Sun; Hui Xu; Rongfen Huo; Beiqing Wang; Baihua Shen; Xiangdong Chen; Ningli Li
Journal:  Clin Immunol       Date:  2016-11-14       Impact factor: 3.969

2.  CCN1, a Pro-Inflammatory Factor, Aggravates Psoriasis Skin Lesions by Promoting Keratinocyte Activation.

Authors:  Yue Sun; Jie Zhang; Zhou Zhou; Pinru Wu; Rongfen Huo; Beiqing Wang; Zhengyu Shen; Huidan Li; Tianhang Zhai; Baihua Shen; Xiangdong Chen; Ningli Li
Journal:  J Invest Dermatol       Date:  2015-06-22       Impact factor: 8.551

3.  Cyr61 induces IL-6 production by fibroblast-like synoviocytes promoting Th17 differentiation in rheumatoid arthritis.

Authors:  Jinpiao Lin; Zhou Zhou; Rongfen Huo; Lianbo Xiao; Guilin Ouyang; Li Wang; Yue Sun; Baihua Shen; Dangsheng Li; Ningli Li
Journal:  J Immunol       Date:  2012-04-30       Impact factor: 5.422

4.  Cyr61 is involved in neutrophil infiltration in joints by inducing IL-8 production by fibroblast-like synoviocytes in rheumatoid arthritis.

Authors:  Xianjin Zhu; Lianbo Xiao; Rongfen Huo; Jie Zhang; Jinpiao Lin; Jun Xie; Songtao Sun; Yong He; Yue Sun; Zhou Zhou; Baihua Shen; Ningli Li
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.